Twist Bioscience (TWST) Depreciation & Amortization (CF) (2017 - 2026)

Twist Bioscience has reported Depreciation & Amortization (CF) over the past 10 years, most recently at $6.4 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) changed 0.19% to $6.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $24.7 million through Mar 2026, down 11.04% year-over-year, with the annual reading at $24.9 million for FY2025, 20.93% down from the prior year.
  • Depreciation & Amortization (CF) was $6.4 million for Q1 2026 at Twist Bioscience, up from $6.2 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $8.5 million in Q3 2023 and troughed at $4.0 million in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $6.4 million (2025), against an average of $6.6 million.
  • Year-over-year, Depreciation & Amortization (CF) soared 103.7% in 2022 and then fell 26.94% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $5.3 million in 2022, then soared by 54.4% to $8.2 million in 2023, then dropped by 21.92% to $6.4 million in 2024, then fell by 2.92% to $6.2 million in 2025, then rose by 3.55% to $6.4 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Depreciation & Amortization (CF) are $6.4 million (Q1 2026), $6.2 million (Q4 2025), and $6.0 million (Q3 2025).